Open AccessAbstract 5876: Osimertinib (AZD9291), a mutant-selective EGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells
Author(s) -
Xiaoyu Zhang,
ZiNing Lei,
Yun-Kai Zhang,
Yijun Wang,
Pranav Gupta,
Leli Zeng,
Megan Xu,
Xiuqi Wang,
DongHua Yang,
ZheSheng Chen
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-5876
Subject(s) - osimertinib , pharmacology , atp binding cassette transporter , cancer cell , paclitaxel , tyrosine kinase inhibitor , cancer research , medicine , biology , cancer , transporter , epidermal growth factor receptor , chemistry , erlotinib , biochemistry , gene